Novartis AG News
Bristol Myers Squibb Shakes Up Key Biotech Battleground
The FDA approval of Sotyktu for psoriasis has both ignited and dampened prospects for smaller biotech stocks.
Biosimilars Are Saving America $1 Billion Per Month
Competitive drug prices are great for consumers. Turns out, they're good for industry, too.
This Small-Cap Biotech is a Sneaky Play on Next-Gen Drugs
Selecta Biosciences is one of the most mature companies in an area attracting the attention of industry titans.
Novartis Follows Eli Lilly with $1.4 Billion Gene Editing Pact
Precision BioSciences is developing gene editing tools with several potential advantages over CRISPR.
Novartis and Roche Have Expensive Drugs That Scare Away Competitors
A brief snapshot of some medical breakthroughs that are among the costliest in the world.
5 Top Stock Gainers for Thursday Amid Central Bank Policy Calls
Stocks were mixed Thursday as investors digested policy decisions made by the U.S. Federal Reserve and the Bank of England.
Emergent BioSolutions Begins Phase 1 Trial for Universal Flu Vaccine
Emergent says its flu-vaccine candidate 'contains multiple components to induce broad, supra-seasonal immunity against influenza A viruses.'
Buyback Bonanza: Novartis May Snap Up $15 Billion of Stock
Swiss drug giant Novartis NVS said it plans to deploy up to $15 billion for share buybacks, thanks to its $21 billion sale of Roche shares.
Premarket Movers Thursday After Bank of England Rate Hike
Stock futures traded higher as investors cheered tighter monetary policies in 2022.
Novartis to Sell Stake in Rival Roche for $20.7 Billion
Novartis says it does not see its stake in Roche as part of its core business.
Tips for Retirees to Deal with Falling Stocks and Bonds
The markets' slide particularly hurts retirees, who may have to sell some of their stocks and bonds to finance spending.
Alphabet CEO Pichai Continues to Sound Alarm About the Economy
The parent company of Google and Youtube is preparing for a sharp deterioration in the health of the economy.